AI assistant
Sending…
Nuvectis Pharma, Inc. — Director's Dealing 2025
Oct 31, 2025
33912_dirs_2025-10-31_ff8d7dfa-4c1c-44f6-9894-1d4ed38a40a2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Nuvectis Pharma, Inc. (NVCT)
CIK: 0001875558
Period of Report: 2025-09-22
Reporting Person: Sanchez Juan (Director)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 35150 | Direct |
| Common Stock | 295 | Indirect |
| Common Stock | 120 | Indirect |
More from Nuvectis Pharma, Inc.
Interim / Quarterly Report
2026
May 5
Earnings Release
2026
May 5
Regulatory Filings
2026
Feb 23
Capital/Financing Update
2026
Feb 13
Earnings Release
2026
Feb 11
Annual Report
2026
Feb 11
Director's Dealing
2026
Jan 9
Director's Dealing
2026
Jan 9
Director's Dealing
2026
Jan 9
Director's Dealing
2026
Jan 9